X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
turbohaler (15) 15
humans (11) 11
respiratory system (11) 11
asthma (8) 8
dry powder inhaler (8) 8
bronchodilator agents - administration & dosage (7) 7
administration, inhalation (6) 6
adult (6) 6
asthma - drug therapy (6) 6
female (6) 6
male (6) 6
child (5) 5
nebulizers and vaporizers (5) 5
budesonide (4) 4
equipment design (4) 4
formoterol fumarate (4) 4
index medicus (4) 4
peak inspiratory flow (4) 4
salmeterol xinafoate (4) 4
turbuhaler (4) 4
adolescent (3) 3
aerosols (3) 3
albuterol - analogs & derivatives (3) 3
asthma - physiopathology (3) 3
children (3) 3
device (3) 3
disease (3) 3
ethanolamines - adverse effects (3) 3
inhalation (3) 3
lung deposition (3) 3
middle aged (3) 3
pharmacology & pharmacy (3) 3
powders (3) 3
terbutaline sulfate (3) 3
adrenal cortex hormones - therapeutic use (2) 2
adrenergic beta-2 receptor agonists - adverse effects (2) 2
aged (2) 2
airway responses (2) 2
albuterol - adverse effects (2) 2
allergy (2) 2
anti-asthmatic agents - adverse effects (2) 2
asthma - mortality (2) 2
beclomethasone - administration & dosage (2) 2
beta-agonists (2) 2
breath-actuated inhalers (2) 2
budesonide - administration & dosage (2) 2
cardiac & cardiovascular systems (2) 2
chronic disease (2) 2
cross-over studies (2) 2
deposition (2) 2
diskus (2) 2
dry powder inhalers (2) 2
dry-powder inhaler (2) 2
eformoterol turbohaler (2) 2
ethanolamines - administration & dosage (2) 2
evaluation studies as topic (2) 2
forced expiratory volume - physiology (2) 2
glucocorticoids - administration & dosage (2) 2
inhalation technique (2) 2
inhaler (2) 2
inhalers (2) 2
intrinsic efficacy (2) 2
long-acting beta-agonists (2) 2
medicine, general & internal (2) 2
metered-dose inhaler (2) 2
metered-dose inhalers (2) 2
new-zealand (2) 2
particle size (2) 2
prescribed fenoterol (2) 2
pressurized aerosol inhalers (2) 2
pulmonary and respiratory medicine (2) 2
randomized controlled trials as topic (2) 2
rotahaler (2) 2
salbutamol (2) 2
self-management (2) 2
abridged index medicus (1) 1
absorption (1) 1
accuhaler (1) 1
activated-charcoal (1) 1
acute bronchoconstriction (1) 1
adrenal cortex hormones [therapeutic use] (1) 1
adrenal suppression (1) 1
adrenergic beta-2 receptor agonists - administration & dosage (1) 1
adrenergic beta-2 receptor agonists - blood (1) 1
adrenergic beta-2 receptor agonists - pharmacokinetics (1) 1
adrenergic beta-agonists - adverse effects (1) 1
adrenergic beta-agonists [adverse effects] (1) 1
aerodynamic assessment (1) 1
aerosol (1) 1
age (1) 1
albuterol - administration & dosage (1) 1
albuterol [adverse effects; analogs & derivatives] (1) 1
amiloride (1) 1
amiloride - administration & dosage (1) 1
anti-asthmatic agents - administration & dosage (1) 1
anti-asthmatic agents [adverse effects] (1) 1
anti-inflammatory agents - pharmacology (1) 1
anti-inflammatory agents - therapeutic use (1) 1
article (1) 1
asthma - diagnosis (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


International Journal of Clinical Pharmacology and Therapeutics, ISSN 0946-1965, 07/2015, Volume 53, Issue 7, pp. 593 - 602
Objective: Budesonide formoterol (BF) Spiromax (R) is a breath-actuated thy-powder inhaler designed to deliver similar combinations of budesonide and... 
Budesonide | Formoterol | Spiromax | Dry-powder inhaler | Turbohaler | Bioequivalence | ACTIVATED-CHARCOAL | MODERATE | EFFICACY | SAFETY | DEPOSITION | formoterol | BUDESONIDE/FORMOTEROL | budesonide | OBSTRUCTIVE PULMONARY-DISEASE | METERED-DOSE INHALER | PHARMACOLOGY & PHARMACY | ABSORPTION | bioequivalence | dry-powder inhaler | Adrenergic beta-2 Receptor Agonists - pharmacokinetics | Bronchodilator Agents - blood | Ethanolamines - adverse effects | Formoterol Fumarate | Glucocorticoids - administration & dosage | Bronchodilator Agents - administration & dosage | Humans | Male | Healthy Volunteers | Equipment Design | Ethanolamines - administration & dosage | Young Adult | Adrenergic beta-2 Receptor Agonists - blood | Ethanolamines - pharmacokinetics | Adrenergic beta-2 Receptor Agonists - adverse effects | Adult | Female | Bronchodilator Agents - adverse effects | Budesonide - pharmacokinetics | Glucocorticoids - adverse effects | Dry Powder Inhalers | Glucocorticoids - blood | Administration, Inhalation | Budesonide - blood | Cross-Over Studies | Ethanolamines - blood | Bronchodilator Agents - pharmacokinetics | Budesonide - adverse effects | Glucocorticoids - pharmacokinetics | Adrenergic beta-2 Receptor Agonists - administration & dosage | Budesonide - administration & dosage | Drug Combinations | Charcoal | Therapeutic Equivalency
Journal Article
European Respiratory Journal, ISSN 0903-1936, 05/1996, Volume 9, Issue 5, pp. 886 - 892
Our aim was to assess the efficacy of budesonide (Pulmicort(R) Turbohale(R), Astra) used as part of a self-management plan in a group of patients with chronic... 
budesonide | Turbohaler | self-management | Asthma | Turbohaler(R) | asthma | RESPIRATORY SYSTEM | FLOW
Journal Article
European Respiratory Journal, ISSN 0903-1936, 11/1999, Volume 14, Issue 5, pp. 1034 - 1037
Journal Article
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, ISSN 0277-0008, 07/1998, Volume 18, Issue 4, pp. 720 - 728
Journal Article
Thorax, ISSN 0040-6376, 04/1996, Volume 51, Issue 4, pp. 433 - 434
Journal Article
JOURNAL OF ASTHMA, ISSN 0277-0903, 1999, Volume 36, Issue 5, pp. 441 - 447
Self-management of asthma and self-treatment of exacerbations are considered important in the treatment of asthma. For successful self-treatment, medication... 
inhalation technique | TURBOHALER | ALLERGY | RESPIRATORY SYSTEM | patient education | PRESSURIZED AEROSOL INHALERS | DISEASE | inhaler design | asthma | BREATH-ACTUATED INHALERS | self-management | METERED-DOSE INHALERS
Journal Article
Annual International Conference of the IEEE Engineering in Medicine and Biology - Proceedings, ISSN 0589-1019, 2003, Volume 4, pp. 3862 - 3865
Conference Proceeding
Thorax, ISSN 0040-6376, 05/1995, Volume 50, Issue 5, pp. 517 - 519
BACKGROUND--The advent of novel treatments such as aerosolized amiloride are potentially useful additions to the therapeutic options available for the... 
Dry powder inhaler | Cystic fibrosis | Amiloride | Turbohaler | TURBOHALER | THERAPY | DRY POWDER INHALER | RESPIRATORY SYSTEM | INHALATION | AMILORIDE | CYSTIC-FIBROSIS | CYSTIC FIBROSIS | Aerosols | Amiloride - administration & dosage | Cystic Fibrosis - drug therapy | Evaluation Studies as Topic | Nebulizers and Vaporizers
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 1995, Volume 119, Issue 1, pp. 91 - 102
Journal Article
International Journal of Pharmaceutics, ISSN 0378-5173, 1995, Volume 119, Issue 1, pp. 103 - 108
Journal Article
Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung, ISSN 0894-2684, 1998, Volume 11, Issue 3, pp. 143 - 152
Journal Article
2000, Volume 3, Issue 7
The current market for dry powder inhalers (DPIs) has over 20 devices in present use and at least another 30 under development. Clinicians recognize that DPIs... 
Dry powder inhaler | Reservoir | Factory | Turbohaler | Diskus
Book Review
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.